Greater illness severity characterises steroid diabetes following acute hospitalisation.
作者信息
Abbas Nadine, Elhassan Mohammad, Kelly Philip, Yorke Richard, Mustafa Omar G, Whyte Martin Brunel
机构信息
King's College, London, UK.
King's College, London, UK
出版信息
Clin Med (Lond). 2019 Jan;19(1):86-87. doi: 10.7861/clinmedicine.19-1-86.
Abstract
摘要
相似文献
1
Greater illness severity characterises steroid diabetes following acute hospitalisation.急性住院后发生的类固醇糖尿病具有更严重的病情特征。
Clin Med (Lond). 2019 Jan;19(1):86-87. doi: 10.7861/clinmedicine.19-1-86.
2
Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.回顾性分析接受糖皮质激素联合全身抗癌治疗患者的血糖监测发生率。
Ann Palliat Med. 2015 Apr;4(2):70-7. doi: 10.3978/j.issn.2224-5820.2015.04.07.
3
Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases.糖皮质激素诱导的糖尿病：原发性肾脏疾病中的患病率及危险因素
Nephron Clin Pract. 2007;105(2):c54-7. doi: 10.1159/000097598. Epub 2006 Nov 29.
4
Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.慢性阻塞性肺疾病加重住院期间发生类固醇诱导性高血糖症的患者发生 2 型糖尿病的风险。
Lung. 2020 Jun;198(3):525-533. doi: 10.1007/s00408-020-00356-z. Epub 2020 Apr 28.
5
A study of steroid-induced diabetes mellitus in leprosy.一项关于麻风病中类固醇诱导的糖尿病的研究。
Indian J Lepr. 2009 Jul-Sep;81(3):125-9.
6
Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations.糖皮质激素在非糖尿病和糖尿病患者中诱发的高血糖和糖尿病：文献综述与个人思考
Curr Pharm Biotechnol. 2018;19(15):1210-1220. doi: 10.2174/1389201020666190102145305.
7
Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease.呼吸疾病患者中类固醇诱导性糖尿病的发生率及相关风险因素。
J Korean Med Sci. 2011 Feb;26(2):264-7. doi: 10.3346/jkms.2011.26.2.264. Epub 2011 Jan 24.
8
Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases.神经系统疾病患者的类固醇诱导型糖尿病及相关危险因素
Pharmacotherapy. 2004 Apr;24(4):508-14. doi: 10.1592/phco.24.5.508.33355.
9
Risk factors for the development of glucocorticoid-induced diabetes mellitus.糖皮质激素诱导的糖尿病发生的危险因素。
Diabetes Res Clin Pract. 2015 May;108(2):273-9. doi: 10.1016/j.diabres.2015.02.010. Epub 2015 Feb 21.
10
Myasthenia gravis and diabetes mellitus: a 35-year retrospective study.重症肌无力与糖尿病：一项35年的回顾性研究。
Intern Med. 2007;46(9):557-9. doi: 10.2169/internalmedicine.46.6237. Epub 2007 May 1.
引用本文的文献
1
Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?外源性胰岛素能否改善糖皮质激素和 COVID-19 引起的代谢功能障碍？
Front Endocrinol (Lausanne). 2021 Jun 18;12:649405. doi: 10.3389/fendo.2021.649405. eCollection 2021.
本文引用的文献
1
Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.高血糖和类固醇（糖皮质激素）治疗的管理：联合英国糖尿病学会（JBDS）住院治疗组的指南。
Diabet Med. 2018 Aug;35(8):1011-1017. doi: 10.1111/dme.13675.
2
How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment?接受糖皮质激素治疗的住院患者，医院对其进行床边血糖水平测量的频率如何？
Clin Med (Lond). 2014 Jun;14(3):327-8. doi: 10.7861/clinmedicine.14-3-326a.
3
Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.危重症患者的血糖异常和慢性与急性血糖交互作用与死亡率的关系。
Intensive Care Med. 2014 Jul;40(7):973-80. doi: 10.1007/s00134-014-3287-7. Epub 2014 Apr 24.
4
Stress hyperglycaemia.应激性高血糖症
Lancet. 2009 May 23;373(9677):1798-807. doi: 10.1016/S0140-6736(09)60553-5.
5
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.高血糖：未确诊糖尿病患者院内死亡的独立标志物。
J Clin Endocrinol Metab. 2002 Mar;87(3):978-82. doi: 10.1210/jcem.87.3.8341.
Zotero 插件